Results 241 to 250 of about 38,059 (319)

International Swiss Primary Hypersomnolence and Narcolepsy Cohort Study (iSPHYNCS): the impact of psychiatric comorbidities on daily life in central disorders of hypersomnolence—a vicious circle

open access: yesJournal of Sleep Research, Volume 34, Issue 3, June 2025.
Summary Presence of psychiatric comorbidities is well documented in narcolepsy type‐1 (NT1) but there are limited data on patients with ‘other central disorders of hypersomnolence’ (OCH). This study aimed to investigate frequency of psychiatric comorbidities in patients with NT1 and OCH, and to evaluate their impact on quality of life and sleep as an ...
Merve Aktan Suzgun   +13 more
wiley   +1 more source

Overnight changes in performance fatigability and their relationship to modulated deep sleep oscillations via auditory stimulation

open access: yesJournal of Sleep Research, Volume 34, Issue 3, June 2025.
Summary Deep sleep oscillations are proposed to be central in restoring brain function and to affect different aspects of motor performance such as facilitating the consolidation of motor sequences resulting in faster and more accurate sequence tapping. Yet, whether deep sleep modulates performance fatigability during fatiguing tasks remains unexplored.
Manuel Carro‐Domínguez   +10 more
wiley   +1 more source

Music cue during slow wave sleep improves visuospatial memory consolidation

open access: yesJournal of Sleep Research, Volume 34, Issue 3, June 2025.
Summary The active system consolidation theory assumes that sleep between encoding and retrieval promotes memory consolidation. In the present study, we cued new memories during slow‐wave (SWS) or rapid eye movements (REM) sleep stages by presenting an instrumental music stimuli that had been previously presented during a learning session.
Marco Fabbri   +6 more
wiley   +1 more source

General Dentists and Dental Specialists' Knowledge of Treatment, Diagnosis, Referral, and Risk Factors of Obstructive Sleep Apnea: A Systematic Review. [PDF]

open access: yesDent J (Basel)
Alkharouby SA   +7 more
europepmc   +1 more source

Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by CPAP: Randomised phase 3 study

open access: yesJournal of Sleep Research, Volume 34, Issue 3, June 2025.
Summary Obstructive sleep apnea (OSA) syndrome commonly leads to excessive daytime sleepiness (EDS). Pitolisant, a selective histamine‐3 receptor antagonist, is efficacious at doses up to 20 mg once daily in OSA treated or not with continuous positive airway pressure (CPAP).
Yves Dauvilliers   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy